Naropin

ropivacaine hydrochloride

Solution (injection) · NDA 020533

Last listed protection ends

November 28, 2026

The FDA lists 1 patent for Naropin, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities